Uptake of 3‐iodothyronamine hormone analogs inhibits the growth and viability of cancer cells

por Rogowski, Michael, Gollahon, Lauren, Chellini, Grazia, Assadi‐Porter, Fariba M.
Publicado 2017

Metabolic profiling reveals reprogramming of lipid metabolic pathways in treatment of polycystic ovary syndrome with 3‐iodothyronamine

por Selen Alpergin, Ebru S., Bolandnazar, Zeinab, Sabatini, Martina, Rogowski, Michael, Chiellini, Grazia, Zucchi, Riccardo, Assadi‐Porter, Fariba M.
Publicado 2017

Lipolytic Effects of 3-Iodothyronamine (T1AM) and a Novel Thyronamine-Like Analog SG-2 through the AMPK Pathway

por Rogowski, Michael, Bellusci, Lorenza, Sabatini, Martina, Rapposelli, Simona, Rahman, Shaikh M., Chiellini, Grazia, Assadi-Porter, Fariba M.
Publicado 2019